A lot of people with alcohol use disorder (AUD)—a medical condition that makes it hard to stop or control your drinking even ...

Pharma Two B Ltd. (“Pharma Two B”), a late-clinical stage company that is developing P2B001, an innovative combination product candidate for the treatment of Parkinson’s Disease (“PD”) and Hepion ...

A 48-year-old A was recommended to see gastrointestinal internal medicine due to elevated liver levels during a recent ...

Learn about HMGB1's crucial role in liver diseases, its pathways and therapeutic potential that can treat liver diseases.

Weight-loss drugs, particularly newer options like GLP-1 receptor agonists, are revolutionising the treatment of obesity and ...

This review discussed experimental mouse models used in the pre-clinical study of liver fibrosis regression, a pivotal ...

Data reveals that hospital admissions for liver disease jumped by 22 per cent in just one year. NHS figures indicate there ...

Acute liver injury (ALI) caused by acetaminophen (APAP) overdose, hepatic ischemia-reperfusion injury (HIRI), and chronic ...

A recent study highlights the importance of zinc in patients with severe liver disease, especially those suffering from a brain-related complication called hepatic encephalopathy (HE). Conducted at ...

Bilirubin, the byproduct of hemoprotein breakdown, particularly hemoglobin, is a critical marker in diagnosing, prognosing, ...

Blue Heron’s methods emphasize slow but sustainable lifestyle shifts, making it an appealing option for those wary of ...

Substantial enrollment progress in Phase 1b trial of SZN-043 in severe alcohol-associated hepatitis patients with proof-of-concept data expected ...